November 27, 2020
Never forget gravity as a force with a laundry list included …
Pre-open indications: 6 BUYs and 9 SELLs
News: Biogen (BIIB) and Sage Therapeutics (SAGE) enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324 in the U.S.
What I provide is an “intelligence daily” to ensure that shareholders are kept apprised based on a 24-hour surveillance of “our” universe, the RegMed/cell and gene therapy sector and its surrounding markets
Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!
November 28, 2020
A scorecard of 34 earnings releases and 1 acquisition of 35 covered companies
The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status"
November 27, 2020
Week in review
Pre-open indication results: 14 HITs and 1 MISS as Selling into Strength (some partial positions) put money ($) in your portfolio before its stripped
An “intelligence newspaper” for smart investing in the RegMed, gene and cell therapy sector. I track the numbers, so there’s no question re my opinion; so, you can do what others can't.
Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!
November 28, 2020
A scorecard of 34 earnings releases and 1 acquisition of 35 covered companies The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status"
November 4, 2020
BLCM priced offering at $6.025 raising $25 million
September 15, 2020
A scorecard of 1 restatement and 1 acquisition of 35 covered companies The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status"
November 28, 2020
RegMed/Cell and Gene Therapy Earnings Scorecard Q3/20 LPS Results
November 27, 2020
RegMed Investors’ (RMi) closing bell: an early and another record close, as we inch towards a virus containment
November 27, 2020
RegMed Investors’ (RMi) pre-open: volume was light Wednesday; will it be a lazy session today?
November 26, 2020
Happy Thanksgiving ... giving thanks and be SAFE!
November 25, 2020
RegMed Investors’ (RMi) closing bell: some momentum equities acceded to the falling knife’s theory
November 25, 2020
RegMed Investors’ (RMi) pre-open: slipping on slippers, won’t go far
November 24, 2020
RegMed Investors’ (RMi) closing bell: today was supposed to be a catch-up trade in the sector, ended a set-up for the algorithms to reap profit
November 24, 2020
RegMed Investors’ (RMi) pre-open: one set of uncertainties decline as transition begins
© 2020 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
